Steps to Conduct Medical Device Clinical Trials in Türkiye: A Practical Guide to Medical Device Trial Steps
- Merter Ortac
- Jul 13
- 2 min read
Conducting medical device clinical trials in Türkiye requires a clear understanding of regulatory requirements and operational procedures. This guide outlines the essential steps to navigate the process efficiently. It targets pharmaceutical, MedTech, biotech companies, and startups aiming to conduct trials in Türkiye.
Understanding Regulatory Framework and Approval Process
The first step involves familiarizing with Türkiye's regulatory environment. The Turkish Medicines and Medical Devices Agency (TITCK) oversees clinical trial approvals. Companies must submit a detailed application including device description, risk classification, and clinical evaluation reports.
Key documents include:
Investigational Plan
Investigator’s Brochure
Informed Consent Forms
Ethics Committee Approval
Approval timelines vary but typically take 60 days. Early engagement with TITCK can expedite the process. Compliance with Turkish and international standards such as ISO 14155 is mandatory.
Medical Device Trial Steps: Planning and Site Selection
Planning is critical for successful trials. Define objectives, endpoints, and patient population clearly. Select clinical sites with experience in medical device trials and access to the target patient group.
Steps include:
Develop a detailed protocol aligned with regulatory requirements.
Identify and contract qualified clinical sites.
Train site staff on device use and trial procedures.
Establish data management and monitoring plans.
Site selection impacts recruitment speed and data quality. Consider hospitals with specialized departments relevant to the device.
Preparing Documentation and Ethical Approvals
Ethical approval is mandatory before trial initiation. Submit the protocol and informed consent forms to local ethics committees. Ensure documents are in Turkish and comply with local ethical standards.
Documentation must include:
Risk assessment
Patient information sheets
Data protection measures
Ethics committees review patient safety and trial integrity. Approval can take 30-60 days. Maintain transparent communication with committees to address queries promptly.
Conducting the Clinical Trial: Execution and Monitoring
Once approvals are secured, initiate the trial according to the protocol. Monitor patient recruitment, data collection, and device performance closely. Use electronic data capture systems to enhance accuracy.
Key actions:
Regular site visits and audits
Adverse event reporting
Data quality checks
Interim analysis as per protocol
Effective monitoring ensures compliance and identifies issues early. Engage experienced clinical research associates to oversee trial conduct.
Data Analysis and Reporting
After trial completion, analyze data to assess device safety and efficacy. Prepare a comprehensive clinical study report following regulatory guidelines. Include statistical analysis, adverse event summaries, and conclusions.
Submit the report to TITCK for final evaluation. Positive outcomes support device registration and market access in Türkiye.
Post-Trial Obligations and Market Access
Post-trial responsibilities include:
Reporting serious adverse events
Device performance monitoring in real-world use
Compliance with post-market surveillance requirements
Successful trials facilitate faster regulatory approval and reimbursement negotiations. Establish a local presence or partnership to support ongoing compliance.
Following these medical device trial steps ensures a structured approach to clinical trials in Türkiye. Efficient planning, regulatory compliance, and rigorous monitoring are essential for success. Companies benefit from Türkiye’s growing clinical research infrastructure and strategic location.
For more detailed guidance on medical device clinical trials, consult specialized clinical research organizations with local expertise.
